Achilles Therapeutics (ACHL)
NASDAQ: ACHL
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM
Achilles Therapeutics Fail-to-Deliver
Total FTD Shares
5.47K
Below Average
FTD / Avg. Volume
0.43%
Low Impact
1-Year Change
-70.4%
Negative Trend
FTD Chart
As of Mar 18, 2025,
Achilles Therapeutics has
5,471
shares failed to deliver, representing 0.43%
of the average daily volume of
1,281,745
shares. Over the past year, the monthly average FTD is
22,716
shares, with the current level 76% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Mar 18, 2025 | 1.49 | 5.47K | -53.73% |
| Feb 28, 2025 | 1.38 | 11.82K | +52.74% |
| Jan 29, 2025 | 1.13 | 7.74K | +3.24% |
| Dec 31, 2024 | 1.14 | 7.5K | +30.33% |
| Nov 26, 2024 | 1.07 | 5.75K | +77.32% |
| Oct 17, 2024 | 0.99 | 3.25K | -47.20% |
| Sep 25, 2024 | 0.9551 | 6.15K | +3997.33% |
| Aug 05, 2024 | 0.7701 | 150 | -91.62% |
| Jun 20, 2024 | 0.85185 | 1.79K | +13.72% |
| May 31, 2024 | 0.92 | 1.57K | -78.87% |
| Apr 25, 2024 | 0.7744 | 7.45K | +2228.13% |
| Mar 27, 2024 | 1.19 | 320 | -99.19% |
| Feb 29, 2024 | 1.32 | 39.45K | +666.67% |
| Jan 29, 2024 | 0.9501 | 5.15K | -67.61% |
| Dec 29, 2023 | 0.889 | 15.89K | +2192.35% |
| Nov 30, 2023 | 0.826 | 693 | -65.68% |
| Oct 27, 2023 | 0.8897 | 2.02K | -57.76% |
| Sep 29, 2023 | 0.9099 | 4.78K | -86.33% |
| Aug 03, 2023 | 0.995 | 34.96K | +37493.55% |
| Jul 26, 2023 | 1.02 | 93 | -65.43% |
| Jun 29, 2023 | 0.965 | 269 | -72.44% |
| May 26, 2023 | 1.01 | 976 | +169.61% |
| Apr 28, 2023 | 0.83 | 362 | +417.14% |
| Mar 24, 2023 | 0.845 | 70 | -99.53% |
| Feb 24, 2023 | 1.12 | 15.03K | +536.95% |
| Jan 26, 2023 | 1.15 | 2.36K | n/a |